Con: preventing stroke after cardiopulmonary bypass does not require pharmacologic neuroprotection.
Rogers
A
A
Department of Anesthesiology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27157-1009, USA.
D001463:Barbiturates / Q000627:therapeutic use; D001831:Body Temperature; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D017548:Echocardiography, Transesophageal; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000517:prevention & control; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009553:Nimodipine / Q000627:therapeutic use
D001463:Barbiturates; D018696:Neuroprotective Agents; D009553:Nimodipine